Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cancer vaccines based on the identification of genes encoding cancer regression antigens.

× No keyword cloud information.

77 in total

1. Recombinant vaccinia viruses. Design, generation, and isolation.

Authors: C C Broder; P L Earl
Journal: Mol Biotechnol Date: 1999-12-15 Impact factor: 2.695

Review 2. Autologous and allogeneic high-dose therapy for melanoma.

Authors: K A Margolin
Journal: Curr Oncol Rep Date: 2001-07 Impact factor: 5.075

Review 3. Hypopigmentary skin disorders: current treatment options and future directions.

Authors: Anke Hartmann; Eva-B Bröcker; Jürgen C Becker
Journal: Drugs Date: 2004 Impact factor: 9.546

4. In vitro induction of anterior gradient-2-specific cytotoxic T lymphocytes by dendritic cells transduced with recombinant adenoviruses as a potential therapy for colorectal cancer.

Authors: Hyun Ju Lee; Cheol Yi Hong; Mi Hyun Kim; Youn Kyung Lee; Thanh Nhan Nguyen-Pham; Byoung Chul Park; Deok Hwan Yang; Ik Joo Chung; Hyeoung Joon Kim; Je Jung Lee
Journal: Exp Mol Med Date: 2012-01-31 Impact factor: 8.718

5. Natural variation of the expression of HLA and endogenous antigen modulates CTL recognition in an in vitro melanoma model.

Authors: J N Cormier; M C Panelli; J A Hackett; M P Bettinotti; A Mixon; J Wunderlich; L L Parker; N P Restifo; S Ferrone; F M Marincola
Journal: Int J Cancer Date: 1999-03-01 Impact factor: 7.396

6. Spontaneous proliferation and type 2 cytokine secretion by CD4+T cells in patients with metastatic melanoma vaccinated with antigen-pulsed dendritic cells.

Authors: A Karolina Palucka; John Connolly; Hideki Ueno; John Kohl; Sophie Paczesny; Madhav Dhodapkar; Joseph Fay; Jacques Banchereau
Journal: J Clin Immunol Date: 2005-05 Impact factor: 8.317

Cancer vaccines based on the identification of genes encoding cancer regression antigens.

1. Recombinant vaccinia viruses. Design, generation, and isolation.

Review 2. Autologous and allogeneic high-dose therapy for melanoma.

Review 3. Hypopigmentary skin disorders: current treatment options and future directions.

4. In vitro induction of anterior gradient-2-specific cytotoxic T lymphocytes by dendritic cells transduced with recombinant adenoviruses as a potential therapy for colorectal cancer.

5. Natural variation of the expression of HLA and endogenous antigen modulates CTL recognition in an in vitro melanoma model.

6. Spontaneous proliferation and type 2 cytokine secretion by CD4+T cells in patients with metastatic melanoma vaccinated with antigen-pulsed dendritic cells.

Review 7. Hampering immune suppressors: therapeutic targeting of myeloid-derived suppressor cells in cancer.

Review 8. Prospects and challenges of building a cancer vaccine targeting telomerase.

9. Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment.

10. Can immunotherapy by gene transfer tip the balance against colorectal cancer?